The Epidemiology of Inflammatory Breast Cancer

Seminars in Oncology

Volumn 35, Issue 1, 2008, Pages 11-16

  Levine, Paul H ^a   Veneroso, Carmela ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER;

ADVANCED CANCER; ARTICLE; BODY MASS; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; INFLAMMATORY BREAST CANCER; LABORATORY TEST; NORTH AFRICA; OBESITY; ONSET AGE; OUTCOME ASSESSMENT; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; SOCIAL STATUS; UNITED STATES;

BREAST NEOPLASMS; FEMALE; HUMANS; INFLAMMATION; LABORATORY TECHNIQUES AND PROCEDURES; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 39549100345     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2007.11.018     Document Type: Article

References (33)

1. Hance K.W., Anderson W.F., Devesa S.S., Young H.A., and Levine P.H. Trends in inflammatory breast carcinoma incidence and survival: the Surveillance, Epidemiology, and End Results program at the National Cancer Institute. J Natl Cancer Inst 97 (2005) 966-975
2. Tabbane F., Muenz L., Jaziri M., Cammoun M., Belhassen S., and Mourali N. Clinical and prognostic features of a rapidly progressing breast cancer in Tunisia. Cancer 40 (1977) 376-382
3. Greene F.L., Page D.L., Fritz A., Balch C.M., Haller D.G., and Morrow M. Breast. AJCC cancer staging manual (2002), Springer-Verlag, New York 255-281
4. Kim T., Lau J., and Erban J. Lack of uniform diagnostic criteria for inflammatory breast cancer limits interpretation of treatment outcomes: a systematic review. Clin Breast Cancer 7 (2006) 386-395
5. Anderson W.F., Schairer C., Chen B.E., Hance K.W., and Levine P.H. Epidemiology of inflammatory breast cancer (IBC). Breast Dis 22 (2005-6) 9-23
6. Bell C. A system of operative surgery Vol. 2 (1814), Hale & Homser, Hartford, CT 136
7. Lee B., and Tannenbaum N. Inflammatory carcinoma of the breast: a report of twenty-eight cases from the breast clinic of Memorial Hospital. Surg Gynecol Obstet 39 (1924) 580-595
8. Bryant T. Disease of the breast. Wood Medical and Surgical Mongraphs IV (1889)
9. Taylor G., and Meltzer A. "Inflammatory carcinoma" of the breast. Am J Cancer 33 (1938) 33-49
10. Saltzstein S.L. Clinically occult inflammatory carcinoma of the breast. Cancer 34 (1974) 382-388
11. Lucas F.V., and Perez-Mesa C. Inflammatory carcinoma of the breast. Cancer 41 (1978) 1595-1605
12. Amparo R.S., Angel C.D., Ana L.H., Antonio L.C., Vicente M.S., Carlos F.M., et al. Inflammatory breast carcinoma: pathological or clinical entity?. Breast Cancer Res Treat 64 (2000) 269-273
13. Levine P.H., Steinhorn S.C., Ries L.G., and Aron J.L. Inflammatory breast cancer: the experience of the Surveillance, Epidemiology, and End Results (SEER) program. J Natl Cancer Inst 74 (1985) 291-297
14. Chang S., Parker S.L., Pham T., Buzdar A.U., and Hursting S.D. Inflammatory breast carcinoma incidence and survival: the Surveillance, Epidemiology, and End Results program of the National Cancer Institute, 1975-1992. Cancer 82 (1998) 2366-2372
15. Wingo P.A., Jamison P.M., Young J.L., and Gargiullo P. Population-based statistics for women diagnosed with inflammatory breast cancer (United States). Cancer Causes Control 15 (2004) 321-328
16. Mourali N., Tabbane F., Muenz L.R., Behi J., Ben Moussa F., Jaziri M., et al. Ten-year results utilizing chemotherapy as primary treatment in nonmetastatic, rapidly progressing breast cancer. Cancer Invest 11 (1993) 363-370
17. Levine P.H., Cartin B.J., Low J.A., et al. Improving the case definition of inflammatory breast cancer. Breast Cancer Res Treat 94 Suppl 1 (2005) S89
18. Portera C.C., Yang S.X., Wedam S.B., et al. Evaluation of E-cadherin expression and lymphatic involvement in inflammatory breast cancer. Breast Cancer Res Treat 96 Suppl 1 (2006) S177
19. Denoix P. Treatment of malignant breast cancer. Recent Results Cancer Res 31 (1970) 92-94
20. Mourali N., Muenz L.R., Tabbane F., Belhassen S., Bahi J., and Levine P.H. Epidemiologic features of rapidly progressing breast cancer in Tunisia. Cancer 46 (1980) 2741-2746
21. Attia-Sobol I., Ferrier L.P., Cure H., et al. Treatment results, survival and prognostic factors in 109 inflammatory breast cancer patients: univariate and multivariate analysis. Eur J Cancer 29A (1993) 1081-1088
22. Bonnier P., Charpin C., Lejeune C., Romain S., Tubiana N., Beedassy B., et al. Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition?. Int J Cancer 62 (1995) 382-385
23. Maalej M., Frikha H., Ben Salem S., Daoud J., Bouaouina N., Ben Abdallah M., et al. Breast cancer in Tunisia: clinical and epidemiological study. Bull Cancer 86 (1999) 302-306
24. Anderson W.F., Chu K.C., and Chang S. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?. J Clin Oncol 21 (2003) 2254-2259
25. American Cancer Society. Cancer Facts and Figures (2007). http://www.cancer.org/STT/CAFF2007PWSecured.pdf http://www.cancer.org/STT/CAFF2007PWSecured.pdf
26. Chang S., Buzdar A.U., and Hursting S.D. Inflammatory breast cancer and body mass index. J Clin Oncol 16 (1998) 3731-3735
27. Levine P.H. Factors for the development of aggressive inflammatory and non-inflammatory breast cancer. Breast Cancer Res Treat 88 Suppl 1 (2004) S91
28. Swanson C.A., Brinton L.A., Taylor P.R., et al. Body size and breast cancer risk assessed in women participating in the Breast Cancer Detection Demonstration Project. Am J Epidemiol 130 (1989) 1133-1141
29. Le M.G., Arriagada R., Bahi J., et al. Are risk factors for breast similar in women with inflammatory breast cancer and in those with non-inflammatory breast cancer?. Breast 15 (2006) 355-362
30. Levine P.H., Mesa-Tejada R., Keydar I., et al. Increased incidence of mouse mammary tumor virus-related antigen in Tunisian patients with breast cancer. Int J Cancer 33 (1984) 305-308
31. Levine P.H., Pogo B.G., Coronel S., Woodson K., Klouj A., Melana S.M., et al. Increasing evidence for a human breast cancer virus with geographic differences. Cancer 101 (2004) 721-726
32. Shiramizu B., Barriga F., Neequaye J., et al. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. Blood 77 (1991) 1516-1526
33. Levine P.H., Kamaraju L.S., Connelly R.R., et al. The American Burkitt's lymphoma registry: eight years' experience. Cancer 49 (1982) 1016-1022